Authors


Orly Avitzur, MD, MBA

Latest:

How Does Your Practice Compare? A How-To Guide to Practice Benchmarking

Everyone is talking about the decline in reimbursements and the increase in overhead costs. While most practices are faltering, some are quite successful--that is, they are economically thriving. So what makes the difference?


Osborne P. Wiggins, PhD

Latest:

The Crisis of Present-Day Psychiatry: Regaining the Personal

Present-day psychiatry has fallen into crisis because of the severe limitations of its conception of the person and, as a result, its conception of the patient. It objectifies the patient in a number of ways. Because of this reductionism, psychiatry fails to distinguish between healthy and pathological features of human life. It fails to consider adequately the psychological and social factors that cause and maintain each patient's problems.


Oscar G. Bukstein, MD, MPH

Latest:

New Agents of AbuseUnderstanding Prescription Drug Misuse by Adolescents

A large percentage of youths use and abuse psychoactive substances. According to the 2007 Monitoring the Future (MTF) survey, the percentage of US adolescents who used illicit drugs or drank alcohol continued a decade-long drop, revealing that 19% of 8th grad­ers, more than 36% of 10th graders, and 47% of all 12th graders have taken an illicit drug (other than alcohol) during their lifetime.1 According to the National Survey on Drug Use and Health, the rate was 3.3% for misuse or nonmedical use of prescription drugs.2 The misuse of prescription drugs among adolescents was second only to marijuana use. In fact, prescription drugs increasingly have become a part of the repertoire of drug-using adolescents.


Otto Kausch, MD

Latest:

Reactivation of PTSD Symptoms Resulting From Sandy Hook Media Exposure

Combat veterans who have suffered a moral injury in the past may be predisposed to a recurrence of the painful memories associated with previous trauma after exposure to similar traumatic events with moral overtones.


Ovidio Bermudez, MD

Latest:

Eating Disorders: Much Progress but Still Far to Go

Psychiatry has seen a transition from art to science in the past century and, largely because of 2 developments in the past several decades, this has also been the case for the field of eating disorders.


P. A. Newton, MD, MPH, MA

Latest:

Black Psychiatrists of America Speak About Desmond Tutu

On behalf of the Black Psychiatrists of America, we are writing to the American Psychiatric Association regarding the recent “issues” that have been raised by some members of your association with respect to Archbishop Tutu being this year’s convocation speaker at your annual meeting in Hawaii in May.


P. Alex Mabe, PhD

Latest:

Peer Specialists as Educators for Recovery-Based Systems Transformation

Project GREAT efforts in psychoeducation are geared toward educating providers about recovery so that they can, in turn, transform their own practices to be in concert with the recovery model.


Pam Factor-Litvak, PhD

Latest:

The Impact of Life Stresses on Semen Quality

A recently published study found that certain types of stress affect the quality and quantity of men's sperm. The senior author of that study addresses the topic and provides take-away points for psychiatrists in this brief podcast.


Pamela K. Keel, PhD

Latest:

Purging Disorder

A syndrome described as purging following the ingestion of normal or small amounts of food in normal-weight persons has gained increasing attention in the field of eating disorders. Various terms have been used in the literature for this newly characterized syndrome, with purging disorder and eating disorder not otherwise specified-purging (only), or EDNOS-P, used most frequently.


Pamela Lusk, DNP

Latest:

Opportunities and Challenges in Treating Adolescents and Young Adults With Major Depressive Disorder

Half of all mental health disorders occur by age 14. Early interventions may mitigate progression to more serious and persistent mental health concerns.


Pamela S. Wiegartz, PhD

Latest:

Issues in Treating Anxiety Disorders in Pregnancy

Anxiety disorders are a frequent occurrence in pregnancy. While some worries and anxiety are experienced by more than 50% of pregnant women, a full-blown anxiety disorder involves risk to both mother and fetus and increases the risk of postpartum depression.


Pascal Sienaert, MD, PhD

Latest:

Managing the Adverse Effects of Antidepressants

Most, if not all, antidepressants can cause bothersome adverse effects. These are described here along with strategies to help patients cope.


Patricia A. Arean, PhD

Latest:

Psychotherapy for Late-Life Depression

This article provides a practical overview of the available evidence-based treatment and discusses circumstances in which certain interventions may be preferred over others.


Patricia A. Boyle, PhD

Latest:

Apathy and Its Treatment in Alzheimer's Disease and Other Dementias

Affecting 70% of patients with Alzheimer's disease and common in patients suffering from other dementing illnesses, apathy is associated with functional impairment and caregiver distress at all levels of disease severity. Assessment and treatment for this under-recognized syndrome are discussed.


Patricia Casey, FRCPI, FRCPsych, MD

Latest:

Adjustment Disorders: Diagnostic and Treatment Issues

Adjustment disorder is one of the few psychiatric diagnoses for which the etiology, symptoms, and course, rather than symptoms alone, are central to making the diagnosis. Both emotional and behavioral disturbances are present and include low mood, tearfulness, anxiety, self-harm, withdrawal, anger, and irritability.


Patricia Junquera, MD

Latest:

“Designer Drug” Use and Abuse: Implications for Psychiatrists

Psychiatrists are urged to familiarize themselves with these new drugs and the typical presentations of patients who use them since implications of misdiagnosis can be far-reaching.


Patricia L. Gerbarg, MD

Latest:

Neurobiology and Neurophysiology of Breath Practices in Psychiatric Care

Slow voluntarily regulated breathing practices are noninvasive, easy to learn, and generally safe for treating patients with symptoms of anxiety, insomnia, depression, stress- and trauma-related disorders, ADHD, schizophrenia, and substance abuse.


Patricia Lester, MD

Latest:

The Long War Comes Home

Most military families successfully adapt to a service member's deployments for military duties. Nevertheless, almost a decade of wartime stress associated with the current wars in Iraq and Afghanistan has presented unprecedented challenges for military families.


Patricia Ordorica, MD

Latest:

Contraception and Misconceptions

Psychiatrists who treat women and adolescent girls may find it necessary to discuss with their patients reproductive planning and the role of contraception in setting comprehensive treatment goals. Here's why.



Patricia Watson, PhD

Latest:

Understanding and Fostering Resilience in Persons Exposed to Trauma

When attempting to incorporate resilience-building strategies into practice, it is worthwhile to note that resilience is a dynamic concept in which successful coping may mean a mixture of major real-life successes in the context of continuing difficulties.


Patrick Abbott, MD

Latest:

Culture and Substance Abuse: Impact of Culture Affects Approach to Treatment

There have been numerous definitions of culture. Dwight Heath1 offers a simple definition: "It [culture] is a system of patterns of belief and behavior that shape the worldview of the member of a society. As such, it serves as a guide for action, a cognitive map, and a grammar for behavior."


Patrick D. Mcgorry, MD, PhD

Latest:

Stage-Specific Treatment of Psychotic Disorders

Psychotic disorders are potentially serious and enduring and have been seriously neglected in health systems worldwide. The good news is that better medium-term outcomes are now achievable.


Patrick J. Haggard, MD

Latest:

Reducing Risk Associated With Seclusion and Restraint

This article briefly reviews the federal standards regarding S/R and methods of reducing the risk associated with their use. CMS standards that went into effect February 6, 2007, will be emphasized; however, some of these standards vary from JCAHO standards.


Patrick J. Lustman, PhD

Latest:

Depression in Adults With Diabetes

Diabetes doubles the likelihood of comorbid depression, which impairs functioning and quality of life. This mood disorder has a unique importance in diabetes because of its associations with treatment noncompliance, insulin resistance, hyperglycemia and an increased risk for diabetes complications.


Patrick Kelly, MD

Latest:

Borderline Personality Disorder: New Reasons for Hope

Borderline Personality Disorder: New Reasons for Hope is one in a series being published by Johns Hopkins University Press on major psychiatric disorders.


Patrick T. Triplett, MD

Latest:

Suicidal Patients: Defining and Addressing Emergencies

Here: a review of issues related to assessment of patients for suicide risk in the ED -- and an overview of emerging approaches and research that one day will lead to more reliable assessment and interventions based more on science than on art or luck.


Patrick W. Conway, MDiv, MS-II

Latest:

Reading the Humanities for Humanity

Cynthia Geppert has done it again! She has written a timely article that expresses what I have thought for a long time (“Why Psychiatrists Should Read the Humanities,” Psychiatric Times, February 2008, page 10). Recently, I was sitting in a nonscience course for first-year medical students wondering why it was difficult for some of them to respond to the professor’s questions.


Paul Aveyard, PhD

Latest:

Quitting Smoking: Therapeutic in Mental Health Treatment

Many patients report that smoking helps them with their stress and psychological disturbances. However, smoking may actually worsen some of these symptoms. When is the right time for your patients to quit?


Paul B. Rosenberg, MD

Latest:

Depression in Patients With Alzheimer Dementia

Alzheimer dementia (AD) represents a profound global health concern. By the year 2050, the prevalence of AD in the United States is expected to reach 15 million. At present, there are 4.5 million cases in the United States, which equals an estimated cost of $100 billion each year in medical and family expenses.

© 2025 MJH Life Sciences

All rights reserved.